Full article: Compounded glucagon like peptide 1 receptor agonists for weight loss: the direct to consumer market in Colorado A new FDA advisory panel meeting, influenced by RFK Jr.'s push for broader access, will weigh the potential benefits and risks of widely promoted peptides. Click the link in bio to read FDA moves toward easing restrictions on certain peptides BioPharma Dive Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law FDA to Review 7 Peptides for Compounding List in July 2026: BPC 157, Semax, Epitalon, and More HealingMaps